SAGE THERAPEUTICS INC (SAGE) Earnings History & Surprises
NASDAQ:SAGE • US78667J1088
8.68 USD
-0.02 (-0.23%)
At close: Jul 30, 2025
8.685 USD
+0.01 (+0.06%)
After Hours: 7/30/2025, 8:00:02 PM
Past quarterly earnings results for SAGE THERAPEUTICS INC (SAGE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateOct 27, 2025
PeriodQ3 / 2025
EPS Estimate-$0.84
Revenue Estimate24.752M
Last Reported
Release DateJul 30, 2025
PeriodQ2 / 2025
EPS Reported-$0.79
EPS Surprise 18.46%
Revenue Surprise 85.16%
Beat Rate
44%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2025 | -0.79 | -0.97 | 18.46% | 53.53% | 31.66M | 17.099M | 85.16% | 265.84% |
| Q1 2025 | -1.01 | -1.02 | 0.49% | 43.89% | 14.063M | 14.424M | -2.50% | 77.97% |
| Q4 2024 | -1.56 | -1.54 | -1.61% | 13.33% | 12.815M | 14.729M | -12.99% | -83.56% |
| Q3 2024 | -1.53 | -1.56 | 2.18% | 54.60% | 11.871M | 11.018M | 7.74% | 337.08% |
| Q2 2024 | -1.70 | -1.69 | -0.48% | 36.57% | 8.654M | 9.025M | -4.11% | 250.36% |
| Q1 2024 | -1.80 | -1.68 | -7.14% | 26.83% | 7.902M | 5.891M | 34.14% | 139.89% |
| Q4 2023 | -1.80 | -1.30 | -38.16% | 27.13% | 77.972M | 62.197M | 25.36% | 2,588.69% |
| Q3 2023 | -3.37 | -2.79 | -21.00% | -45.89% | 2.716M | 4.71M | -42.34% | 59.76% |
| Q2 2023 | -2.68 | -2.60 | -2.89% | -25.82% | 2.47M | 3.002M | -17.72% | 64.67% |
| Q1 2023 | -2.46 | -2.55 | 3.37% | -18.84% | 3.294M | 2.454M | 34.23% | 105.88% |
| Q4 2022 | -2.47 | -2.44 | -1.43% | -16.51% | 2.9M | 1.977M | 46.69% | 81.25% |
| Q3 2022 | -2.31 | -2.25 | -2.60% | -4.52% | 1.7M | 1.672M | 1.67% | 21.43% |
| Q2 2022 | -2.13 | -2.20 | 2.98% | -16.39% | 1.5M | 1.797M | -16.53% | -6.25% |
| Q1 2022 | -2.07 | -2.08 | 0.35% | -26.22% | 1.6M | 3.271M | -51.09% | - |
| Q4 2021 | -2.12 | -2.21 | 4.29% | -111.65% | 1.6M | 2.014M | -20.56% | -99.86% |
| Q3 2021 | -2.21 | -1.89 | -16.91% | -8.87% | 1.4M | 1.998M | -29.93% | -12.50% |
| Q2 2021 | -1.83 | -1.73 | -5.95% | 12.02% | 1.6M | 2.048M | -21.88% | 45.45% |
| Q1 2021 | -1.64 | -1.95 | 15.77% | 32.79% | 1.6M | 2.043M | -21.68% | -30.43% |
| Q4 2020 | 18.19 | -0.36 | 5,163.12% | - | 1.109B | 56.447M | 1,865.03% | - |
| Q3 2020 | -2.03 | -2.43 | 16.61% | - | 1.6M | 1.903M | -15.92% | - |
| Q2 2020 | -2.08 | -2.71 | 23.32% | - | 1.1M | 905.281K | 21.51% | - |
| Q1 2020 | -2.44 | -3.20 | 23.77% | - | 2.3M | 2.852M | -19.35% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
4.88%
Max EPS beat (4)
18.46%
Min EPS beat (4)
-1.61%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
19.35%
Max Revenue beat (4)
85.16%
Min Revenue beat (4)
-12.99%
Analysis
In the last 4 quarters, SAGE has beaten EPS estimates in 3 out of 4 releases
SAGE has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, SAGE has beaten the EPS estimates by 4.9% on average.
In the last 4 quarters, SAGE has beaten the revenue estimates by 19.4% on average.
SAGE THERAPEUTICS INC / SAGE Earnings FAQ
Can you provide the last earnings date for SAGE THERAPEUTICS INC?
SAGE THERAPEUTICS INC (SAGE) last reported earnings on 7/30/2025.
Did SAGE THERAPEUTICS INC (SAGE) beat earnings estimates last quarter?
SAGE THERAPEUTICS INC (SAGE) beat EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often SAGE THERAPEUTICS INC beats earnings estimates?
In the last 4 quarters, SAGE THERAPEUTICS INC (SAGE) has beaten EPS estimates in 3 out of 4 releases.